ãžã§ã³ã»ããžã£ãŒã¹
ã¢ãªãšã«ã»ã€ã³ãã¹ãã¡ã³ã, LLC
ãžã§ã³ã»ããžã£ãŒã¹ã¯1983幎ã«ã¢ãªãšã«ã»ã€ã³ãã¹ãã¡ã³ããèšç«ããŸãããããžã£ãŒã¹ã¯å瀟ã®å°åæ ªããã³äžåæ ªã®æ©é¢æè³å®¶åãããŒããã©ãªãªããªãã³ã«ã¢ãªãšã«ã»ãã¡ã³ãïŒARGFXïŒãšã¢ãªãšã«ã»ã¢ãã¬ã·ãšãŒã·ã§ã³ã»ãã¡ã³ãïŒCAAPXïŒãéçšããŠããŸãããŸãããã©ãŒãã¹èªã§ãå¿è匷ãæè³å®¶ïŒPatient InvestorïŒããšããã³ã©ã ãé·æã«ãããå·çããŠããŸãã
ä¿ææ ªåŒæ°
è³ç£èŠæš¡
% ããã10
99
$9.61B
32.85%
ææ°å€2026Q3
äž»ãªè²·ä»éæ--
äž»ãªå£²åŽéæAQN (US)
ã»ã¯ã¿ãŒå¥é å
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³î®
ã¬ãã«1ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«2ã»ã¯ã¿ãŒå¥å
èš³
ã¬ãã«3ã»ã¯ã¿ãŒå¥å
èš³
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
æè³éè¡ & æè³ãµãŒãã¹
å»çæ©åš & åå
ã¡ãã£ã¢ & åºç
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
é»åæ©åš & éšå
ä¿éº
å°é & 忥ãµãŒãã¹
äžåç£äºæ¥
éè¡ãµãŒãã¹
å»è¬å
ä»ã®
ä¿æéæ
2026Q3î®
2026Q3
2026Q2
2026Q1
2025Q4
2025Q3
2025Q2
2025Q1
çªå·
販売åç§°
ããŒããã©ãªãªã®ãŠã§ã€ã
ååŒæ ªåŒæ°
æäŸ¡ïŒæ¥ä»ïŒ
æäŸ¡ç·é¡
ä¿ææ ªåŒæ°
æ¥çš®
å ±åæ¥
ãŠã©ãããªã¹ã
4.19%
0.00
$402.74M
$402.74M
5.03M
ã¡ãã£ã¢ & åºç
2026-09-30
î
3.73%
0.00
$357.96M
$357.95M
979.09K
æè³éè¡ & æè³ãµãŒãã¹
2026-09-30
î
Charles River Laboratories International Ord Shs (US) (US)
159864107
3.66%
0.00
$352.05M
--
1.19M
--
2026-09-30
î
3.66%
0.00
$351.23M
$350.52M
15.62M
ããã« & ãšã³ã¿ãŒãã€ã³ã¡ã³ããµãŒãã¹
2026-09-30
î
3.01%
0.00
$289.43M
$289.43M
1.40M
æ©æ¢°ãå·¥å
·ã倧åè»äž¡ãéé & è¹è¶
2026-09-30
î
2.43%
0.00
$233.50M
$233.50M
576.25K
ã¡ãã£ã¢ & åºç
2026-09-30
î

